We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of the Safety of Varivax® in Pediatric Renal Transplant Recipients

This study has been terminated.
(Slow enrollment)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00005009
First Posted: August 31, 2001
Last Update Posted: February 16, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Merck Sharp & Dohme Corp.
Cooperative Clinical Trials in Pediatric Transplantation
North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS)
NIAID Vaccine and Treatment Evaluation Units (VTEUs)
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID)
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: June 16, 2001
  Primary Completion Date: June 16, 2001 (Final data collection date for primary outcome measure)